Global Antibiotics Market Overview 2019-2025

The global antibiotics market is expected to reach USD 40.78 billion by 2025. Increasing prevalence of infectious diseases worldwide is a major factor driving the global antibiotics market. Since the discovery of antibiotics in the early 20th century, these have been an essential tool in treating the massive burden of infectious diseases worldwide. Yet antimicrobial resistance or AMR is increasingly threatening the effectiveness of antibiotics, which may restrain their use.

Major players in the global antibiotics market are Abbott Laboratories, Merck & Co. Inc., GlaxoSmithKline Plc, F.Hoffmann-La Roche Ltd., Mylan N.V., Sanofi, Pfizer Inc., Novartis International AG, and Cipla Ltd among others.

Request sample copy of this report at: https://www.adroitmarketresearch.com/contacts/request-sample/1282

Adroit Market Research report on global antibiotics market gives a quantitative narration of the market demand, trends, drivers, restraints and opportunities spanning from 2015 to 2025. Historic trends have been studied from 2015 to 2017, with 2018 the base year of estimation and forecast from 2019-2025. The report contains the present status and future prospects of the market at global as well as country level. Additionally, the market has been assessed based on Porter's five forces analysis, along with the depiction of the industry’s value chain. The global antibiotics market is classified based on drug class and route of drug administration. Moreover, the report offers in-depth assessment of the market competitors along with company profiles of major players serving in the global market.

The global antibiotics market has been segmented into drug class and route of drug administration. Drug class wise the market is broken down into broad spectrum penicillins, cephalosporins, macrolides, quinolones, tetracyclines, narrow spectrum penicillins, trimethoprim & combinations and others. Broad spectrum penicillins is project to be the largest segment through 2025 growing with a CAGR of 5.1%. Its ability to fight wide range of infections is expected to fuel its growth. In the route of administration segment the market has been bifurcated into oral and parenteral routes. The oral route of drug administration is estimated to be the largest segment by 2025.

Read complete report at: https://www.adroitmarketresearch.com/industry-reports/antibiotics-market

North America is expected to dominate the global antibiotics market in 2025 with 34% market share, however, Asia Pacific will grow with a highest CAGR of 5.5% through the forecast period. Many low and middle income countries face both antibiotics excess and access issues. A 2015 study by the Centers for Disease Dynamics and Control found that global antibiotic consumption had increased by 65% in the past 15 years (from 21.1 billion to 34.8 billion defined daily doses). This was driven by rising consumption in low and middle income countries. In India, for example, easy access to the strongest antibiotics is a commonplace. In 2015, antibiotic consumption in India reached 4,950 defined daily doses per 1,000 people, up from 2,645 in 2000. Nevertheless, the burden of infectious diseases in India remains extremely high. Lower respiratory infections, diarrhoeal diseases and tuberculosis are among the ten deadliest diseases in India. Out of every 100,000 children aged under five in 2016, 258 died due to pneumonia, diarrhoea or another common infectious disease. Although infectious disease burdens are also linked to safe water, hygiene and sanitation, these numbers also indicate a clear unmet need for access to appropriate antibiotics.

Key segments of the global antibiotics market

Drug Class Overview, 2015-2025 (USD Billion)

Broad spectrum penicillins
Cephalosporins
Macrolides
Quinolones
Tetracyclines
Narrow spectrum penicillins
Trimethoprim & combinations
Others

Route of Administration Overview, 2015-2025 (USD Billion)

Oral
Parenteral

Regional Overview, 2015-2025 (USD Billion)

North America
US
Canada
Europe
Germany
United Kingdom
France
Rest of Europe
Asia Pacific
China
Japan
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa

Get 10% discount on purchase at: https://www.adroitmarketresearch.com/researchreport/purchase/1282

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market's size, key trends, participants and future outlook of an industry. We intend to become our clients' knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code- Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Ryan Johnson
Account Manager Global
3131 McKinney Ave Ste 600, Dallas,
TX75204, U.S.A.
Phone No.: USA: +1 972-362 -8199/ +91 9665341414

This release was published on openPR.